Oslo, 18 April 2024. Reference is made to the stock exchange notice from
Norwegian Block Exchange AS ("NBX" or the "Company") on 9 and 10 April 2024
regarding the terms of the subsequent offering of up to NOK 2,520,000 through
issuance of up to 4,200,000 new shares (the "Offer Shares") in the Company at a
subscription price of NOK 0.60 per share (the "Subsequent Offering"). 

In the Subsequent Offering, the shareholders in the Company as of the end of
trading on 4 March 2024, as registered in the Norwegian Central Securities
Depositary - Euronext Securities Oslo ("Verdipapirsentralen" or "VPS") on 6
March 2024 (the "Record Date"), who (i) were not allocated offer shares in the
Private Placement and (ii) are not resident in a jurisdiction where such
offering would be unlawful, or for jurisdictions other than Norway, would
require any prospectus filing, registration or similar action (the "Eligible
Shareholders"), received subscription rights giving preferential rights to
subscribe for and be allocated Offer Shares in the Subsequent Offering. In
addition, shareholders and investors that participated in the Private Placement
were given a secondary right to subscribe for Offer Shares not subscribed for by
the Eligible Shareholders.

The subscription period in the Subsequent Offering ended on 17 April 2024 at
16.30 CEST. At the end of the subscription period, the Company has received
subscriptions corresponding to subscription of 5,583,064 Offer Shares. 

The Company's board of directors (the "Board") has now allocated shares in the
Subsequent Offering, which implies that the Company shall issue 4,200,000 new
shares related to the Subsequent Offering. Allocation letters, regarding the
number of shares allocated and the subscription amount to be paid, will be
distributed to the subscribers shortly. 

The completion of the Subsequent Offering, including the issue and delivery of
the Offer Shares, is subject to (i) the Norwegian Financial Supervisory
Authority approving the application for the share capital increase pertaining to
the Private Placement, as resolved by the extraordinary general meeting on 4
April 2024, ii) the corporate resolutions of the Company required to implement
the Subsequent Offering, including issue of the Offer Shares, being validly
made, (iii) the Norwegian Financial Supervisory Authority approving the
application for the share capital increase pertaining to the Subsequent
Offering, and (iv) the share capital increase pertaining to the issuance of the
allocated Offer Shares being validly registered with the Norwegian Register of
Business Enterprises and the allocated Offer Shares being validly issued and
registered in the VPS. The beforementioned (i) to (iv) is referred to as the
"Conditions".  

Subject to timely payment of the Offer Shares by the subscribers and the
Conditions above being satisfied, the share capital increase pertaining to the
Subsequent Offering is expected to be registered with the Norwegian Register of
Business Enterprises on or about 15 May 2024 and the Offer Shares will
thereafter be delivered to the VPS accounts of the subscribers to whom they are
allocated on or about 15 May 2024. Trading in the Offer Shares on Euronext
Growth Oslo is expected to commence on or about 15 May 2024. 

The Offer Shares may not be transferred or traded before they are fully paid,
the share capital increase is registered with the Norwegian Register of Business
Enterprises and the Offer Shares have been delivered to the subscribers VPS
accounts.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

For more information, please contact: 
Stig Kjos-Mathisen, CEO Norwegian Block Exchange AS 
Email: Stig.aleksander.kjos-mathisen@nbx.com  
Tel: +47 93 28 75 72

------------- 
About Norwegian Block Exchange (NBX) 
NBX is a financial services company building products and services based on
digital assets. NBX is registered with the Norwegian Financial Supervisory
Authority and is listed on Oslo Stock Exchange Euronext Growth.